Tesla and SpaceX have escalated their trademark dispute over "Terafab" to federal court, asking a judge to rule that their planned $16.8 billion chip factory does not infringe on a smaller company's existing trademark. The lawsuit marks a significant turning point in what began as quiet negotiations between the companies this summer before talks collapsed in August.

What Sparked the Trademark Fight?

The dispute traces back to May 2026, when Tesla filed three U.S. trademark applications for "Terafab" and "Tesla Terafab," covering semiconductor chips and chip-making services. Five days later, TERA-print LLC, a nanotechnology company that has held a federal trademark for "Tera-Fab" since 2021, responded with a cease and desist letter.

TERA-print manufactures a desktop photolithography printer sold to researchers for sensor and bioengineering work. The company argued that Tesla and SpaceX's use of "Terafab" would confuse consumers familiar with its own trademark. However, Tesla and SpaceX contend the overlap is superficial, given the massive difference in scale and purpose between a tabletop research tool and a sprawling semiconductor manufacturing facility.

What stands out in the legal filings is the timing of TERA-print's own trademark expansion. One day before sending its cease and desist letter on May 22, TERA-print applied to expand its existing registration to cover semiconductor materials, silicon chips, nanoelectronic devices, and AI design services, categories it had not previously claimed. Tesla and SpaceX call that filing opportunistic in their complaint, noting it arrived two months after Tesla's public Terafab announcement and just days after Tesla's own trademark applications were filed.

How Are the Companies Defending Their Position?

Tesla, SpaceX, and xAI met with TERA-print six separate times between June and August, attempting to resolve the dispute directly before the talks collapsed. Rather than wait to be sued, the companies filed for declaratory judgment this week in the U.S. District Court for the Western District of Texas, asking a judge to find that "Terafab" does not infringe on TERA-print's mark.

The companies argue that the Terafab project is planned as a massive complex spanning roughly 100 million square feet at a Grimes County site in Texas. The facility is designed to produce chips for Optimus robots, Tesla's AI computing needs, and SpaceX's orbital data center ambitions, a scale and purpose the companies say no reasonable consumer would confuse with a tabletop lab printer.

Key Differences Between the Two "Terafab" Operations

• TERA-print's Product: A desktop photolithography printer used by researchers for sensor and bioengineering applications since the company registered its trademark in 2021.
• Tesla-SpaceX Terafab: A $16.8 billion semiconductor manufacturing complex spanning approximately 100 million square feet, designed to produce chips for robotics, AI systems, and space infrastructure.
• Market Positioning: TERA-print serves the research and academic sector, while Tesla-SpaceX targets industrial-scale chip production for commercial and aerospace applications.

TERA-print is not backing down from the fight. The company told PCMag it discussed a settlement with Tesla as recently as September 2 and feels misled by what it called Tesla's professed interest in settling.

"TERA-print holds a Defense Department contract to fabricate semiconductors and partially owns Mattiq Inc., an AI company built on TERA-print's products, and that the company will vigorously defend its rights," stated Andrey Ivankin, CTO at TERA-print.

Andrey Ivankin, CTO at TERA-print

What Happens Next?

Whether construction proceeds under the Terafab name now depends on a federal judge in Austin. This trademark fight is the second legal dispute tied to the Terafab project in the past week, following a separate SpaceX suit aimed at keeping company records about the facility out of public view. The outcome could have significant implications for the timeline and branding of one of Musk's most ambitious infrastructure projects.

The case highlights the intersection of intellectual property law and rapid technological development, where established trademark holders and new entrants in emerging industries must navigate competing claims over names and market positioning. For Tesla and SpaceX, the stakes extend beyond the name itself; the Terafab facility represents a critical piece of their broader AI and space infrastructure ambitions, making the legal clarity essential for moving forward with construction and operations.